fda
CRN Applauds Recent House Resolution Recognizing Vitamin D for Decreasing the Severity of COVID-19
The Council for Responsible Nutrition (CRN) applauds U.S. Representative Glenn Grothman (R-WI) for introducing a House Resolution (H. Res. 116) that recognizes the potential role vitamin D may play in decreasing the severity of COVID-19. The resolution calls on the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) ...
FDA Withdraws Draft Guidance on CBD Enforcement Policy
After the Biden administration released a memo on Jan. 20 to all federal agencies informing them of a “regulatory freeze pending review,” the U.S. Food and Drug Administration (FDA) withdrew its “Cannabidiol Enforcement Policy; Draft Guidance for Industry.” Before it was withdrawn, the guidance was at the Office of Management and Budget (OMB) awaiting review. In ...
Oleandrin Not to be Used as a Dietary Supplement Says FDA
On Sept. 4, the U.S. Food and Drug Administration (FDA) rejected an application to market Oleandrin as a dietary supplement, weeks after MyPillow CEO Mike Lindell promoted the extract as a potential treatment for the coronavirus to President Donald Trump and White House officials, according to Forbes. The FDA concluded that Oleandrin cannot legally be considered ...
Dietary Supplement Usage Up Dramatically During Pandemic, New Ipsos-CRN Survey Shows
The Council for Responsible Nutrition (CRN) has issued results of a COVID-19-focused consumer survey that discovered more than two in five (43 percent) of dietary supplement users have changed their supplement routines since the start of the pandemic. Among those who altered their regimens due to COVID-19, 91 percent report increasing their supplement intake which ...
USP Offers Hand Sanitizer Toolkit in Response to the COVID-19 Pandemic
The U.S. Pharmacopeia (USP) is offering an online toolkit with guidelines from major public health organizations on compounding alcohol-based hand sanitizers and the preparation of hand sanitizers by manufacturers, pharmacies and other facilities. The toolkit was developed to help organizations meet the demand for these products, as shortages of commercially manufactured sanitizers have occurred. The toolkit includes important ...
FDA Fails to Deliver Congressionally Mandated Report on CBD Regulations
The U.S. Food and Drug Administration (FDA) failed to meet its deadline to provide a Congressionally mandated report on how it plans to regulate CBD. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy within 120 days and provide an update of its progress after 60 days. The agency’s first report ...
NPA Urges Health Care Professionals to Report Adverse Events for Dietary Supplements
In a letter to leading medical societies, the Natural Products Association (NPA) is urging that health care professionals make recommendations for reporting adverse events for dietary supplements. Manufacturers of dietary supplements are required to submit all information pertaining to adverse events associated with their products to the FDA (U.S. Food and Drug Administration). “Adverse events ...
Senate Confirms Hahn as FDA Commissioner
In a 72-18 Senate vote, Stephen Hahn, MD, FASTRO was confirmed as the new head of the U.S. Food and Drug Administration (FDA), taking charge at a regulatory agency that oversees products ranging from complex cancer drugs, to food, cosmetics, tobacco and CBD. “We look forward to working with Dr. Hahn and his staff to ...
President Trump Nominates Stephen Hahn as FDA Commissioner
According to Politico, President Donald Trump announced last week that he will nominate Stephen Hahn, MD, FASTRO, a cancer specialist and hospital administrator, to lead the FDA (U.S. Food and Drug Administration). Trump had been rumored to make this selection for several months. If confirmed by the Senate, the top FDA post would mark Hahn’s first ...
House of Representatives Instructs FDA to Regulate CBD
Legislation passed the House of Representatives on June 25 that would appropriate $100,000 for the U.S. Food and Drug Administration (FDA) to perform a Health Hazard Evaluation (HHE) and set a safe level of CBD for consumers to use each day. The process would follow the same precedent as red yeast rice, which allows a natural product to ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Natural Practitioner magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
